Keytruda maker releases trial details

Keytruda manufacture MSD has released details of the trial of the drug with lung cancer patients and the potential for its use in mesothelioma treatment. For us, one of the most important statements comes from MSD managing director Riad El-Dada.

“MSD will continue to work with the Federal Government, lung cancer experts and health consumer organisations to ensure KEYTRUDA is added to the PBS for Australians with nonsmall cell lung cancer.”

The full statement can be found in the following link.

Posted in News

Become a member

Benefits of membership include:

  • Phone and peer support for sufferers and carers
  • Regular updates on issues relating to asbestos exposure and disease
  • Occupational therapy assessment and, if needed, follow-up through our contracted occupational therapist
Join today